Data
Click on Protocol Number of interest to view study-related documentation or download data files.
(DTMC data files are under development.)
| Division | Study Number | Title | Investigator(s) | Release Date |
|---|---|---|---|---|
| CTN | NIDA-CTN-0093 | Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool | Gerald Cochran, PhD, T. John Winhusen, Ph.D. | Apr 13, 2023 |
| CTN | NIDA-CTN-0095A2 | Reducing Stigma toward People with Opioid Use Disorder among Primary Care Clinicians | Stephanie Hooker, Ph.D., M.P.H., Rebecca Rossom, M.D., M.S., A. Lauren Crain, Ph.D., Gavin Bart, Ph.D., M.D. | May 24, 2024 |
| DTMC | NIDA-CTO-0001 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Reserpine For The Treatment Of Cocaine Dependence | Eugene Somoza, M.D. | Dec 04, 2014 |
| DTMC | NIDA-CTO-0002 | Safety Evaluation Of Cocaine Treatment Medication, Modafinil: Interactions With Intravenous Cocaine | Robert J. Malcolm, M.D., C. Lindsay DeVane, Pharm.D. | Aug 01, 2016 |
| DTMC | NIDA-CTO-0003 | Assessment Of Potential Interactions Between Intravenous Cocaine And Tolcapone | Thomas F. Newton, M.D. | Aug 01, 2016 |
| DTMC | NIDA-CTO-0004 | Assessment Of Potential Interactions Between Intravenous Methamphetamine And Oral Selegiline | Thomas F. Newton, M.D. | Aug 01, 2016 |
| DTMC | NIDA-CTO-0005 | Double-Blind, Placebo-Controlled Trial Of Ondansetron For The Treatment Of Cocaine Dependence | John D. Roache, Ph.D. | Aug 01, 2016 |
| DTMC | NIDA-CTO-0006 | Cocaine-Metyrapone Interaction Study | Bonita Singal, M.D., T. John Winhusen, Ph.D. | Aug 01, 2016 |
| DTMC | NIDA-CTO-0007 | Phase 2, Double-Blind, Placebo-Controlled Trial Of Cabergoline For The Treatment Of Cocaine Dependence | Steven Shoptaw, Ph.D., Thomas F. Newton, M.D. | Dec 21, 2017 |
| DTMC | NIDA-CTO-0008 | Phase 2, Double-Blind Placebo-Controlled Trial Of Bupropion for the Treatment of Methamphetamine Dependence | Richard Rawson, Ph.D. | May 07, 2018 |